
Efficacy Rate80%
Studies3
Participants2,514
StatusAvailable
PT-141
Bremelanotide
PT-141 (Bremelanotide) is an FDA-approved melanocortin receptor agonist specifically designed to treat hypoactive sexual desire disorder in premenopausal women. Unlike other sexual health treatments, PT-141 works through the central nervous system to enhance sexual desire and arousal rather than affecting blood flow or hormones.
Technical Specifications
Molecular Information
Molecular Weight1025.18 g/mol
FormulaC50H68N14O10
CAS NumberCAS-189691-06-3
Amino Acid Sequence
Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
Storage & Handling
Store in refrigerator (36-46°F). Do not freeze. Protect from light.
STORAGE REQUIREMENTS
Temperature2-8°C (36-46°F)
Light exposureStore in original carton
HumidityDo not freeze
Shelf life21 days after first use
Medical Disclaimer
Clinical data presented is from peer-reviewed studies. Individual results may vary. Consult healthcare professionals before starting treatment. This information is for educational purposes only.